-
Clinical Utility of Multiplex Point of Care (PCR) Compared to Antigen Testing for Influenza-Like Illness in the Hospital Emergency Department
Sep 9, 2025, 16:22 PM -
Clinical Evidence Quality in Appraisals of Drugs for Rare Diseases in England and Germany
Sep 9, 2025, 16:22 PM -
Unveiling the Economic Landscape: Burden of HR/HER2 Locally Recurrent Inoperable or Metastatic Breast Cancer
Sep 9, 2025, 16:22 PM -
Deep Real-World Analysis of Patients With Myelofibrosis Using Natural Language Processing and Machine Learning: A Methods Description
Sep 9, 2025, 16:22 PM -
Baseline Risk Heterogeneity in Cost-Effectiveness Analysis of the Diabetes Prevention Program
Sep 9, 2025, 16:22 PM -
Correlation Between Ultra-Orphan Drug Costs Cost-Effectiveness Metrics and Disease Prevalence
Sep 9, 2025, 16:22 PM -
Systematic Literature Review (SLR) of Efficacy, Health-Related Quality of Life (HRQoL), and Safety of Immunotherapies for Perioperative Treatment of Early Stage Non-Small Cell Lung Cancer (NSCLC)
Sep 9, 2025, 16:22 PM -
Artificial Intelligence Detection of National Clinical Practice Gaps in Hormone-Sensitive Prostate Cancer (HSPC) in Brazil: A Patient-Centered Framework
Sep 9, 2025, 16:22 PM -
Analysis of the Implementation of Additive PICOs in a European Joint Health Technology Assessment Implications of EUHTA for Pharma: A Qualitative Exploration
Sep 9, 2025, 16:22 PM -
Instrumental Variable Treatment Effects Estimation: A Simulation Comparison of Instrumental Variables and OLS Approaches
Sep 9, 2025, 16:22 PM -
Qualitative Literature Review Exploring the Patient Experience of Shortness of Breath in COPD and Asthma
Sep 9, 2025, 16:22 PM -
Survival Trends in Multiple Myeloma by Treatment Era in the United States
Sep 9, 2025, 16:22 PM -
A Case Study Demonstrating the Utility of the High-Tech Hub Electronic Prescribing Facility to Identify Off-Label Prescribing
Sep 9, 2025, 16:22 PM -
Trends in Reimbursement Agreements for Innovative Orphan and Oncological Medicines in Spain 2020-2025
Sep 9, 2025, 16:22 PM -
Embracing the Long-Term in Disruptive Health Innovations: A Strategic Necessity or a Necessary Evil? Cost Utility of Langerhans Islet Grafting in Unstable Type 1 Diabetes
Sep 9, 2025, 16:22 PM -
Comparison of Time-Driven Activity-Based Costs Incurred by Patients and Caregivers Related to Intravitreal Injections for Retinal Vein Occlusion
Sep 9, 2025, 16:22 PM -
Insights and Implications an Analysis of the Studies Undertaken by HTAIn (Health Technology Assessment in India)
Sep 9, 2025, 16:22 PM -
The Burden and Management of Flares Among Pregnant Patients With Generalized Pustular Psoriasis (GPP): Real-World Evidence (RWE) From the Global SCRIPTOR Study
Sep 9, 2025, 16:22 PM -
Exploring the Impact of Socioeconomic Factors on COVID-19 Vaccine Hesitancy in India: What Can We Learn From the COVID-19 Pandemic? A Scoping Review
Sep 9, 2025, 16:22 PM -
Drivers of Improvement in Observed Survival in Malignant Cancer Sites: A Cancer Registry Analysis
Sep 9, 2025, 16:22 PM
